Stockscreener 앱 받기
1.36
6.21%
-0.09
시간 외 거래:
1.40
0.04
+2.94%
전일 마감가:
$1.45
열려 있는:
$1.45
하루 거래량:
1.22M
Relative Volume:
0.60
시가총액:
$69.01M
수익:
-
순이익/손실:
$-67.68M
주가수익비율:
-0.8193
EPS:
-1.66
순현금흐름:
$-54.24M
1주 성능:
-5.56%
1개월 성능:
-9.93%
6개월 성능:
-48.68%
1년 성능:
-66.08%
1일 변동 폭
$1.35
$1.45
1주일 범위
$1.35
$1.5592
52주 변동 폭
$0.9857
$6.26
Cabaletta Bio Inc Stock (CABA) Company Profile
명칭
Cabaletta Bio Inc
전화
(267) 759-3100
주소
2929 ARCH STREET, PHILADELPHIA, PA
CABA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CABA
Cabaletta Bio Inc
|
1.36 | 130.42M | 0 | -67.68M | -54.24M | -1.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-20 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-12-19 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-10-10 | 개시 | UBS | Buy |
| 2024-02-05 | 개시 | Jefferies | Buy |
| 2023-11-29 | 개시 | William Blair | Outperform |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-19 | 개시 | Stifel | Buy |
| 2023-09-05 | 개시 | Citigroup | Buy |
| 2023-07-18 | 개시 | Guggenheim | Buy |
| 2023-01-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-08-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-08 | 개시 | Wells Fargo | Overweight |
| 2021-10-19 | 재개 | Morgan Stanley | Overweight |
| 2021-06-30 | 개시 | Mizuho | Buy |
| 2021-01-08 | 개시 | Chardan Capital Markets | Buy |
| 2020-10-13 | 개시 | H.C. Wainwright | Buy |
| 2019-11-19 | 개시 | Cowen | Outperform |
| 2019-11-19 | 개시 | Evercore ISI | Outperform |
| 2019-11-19 | 개시 | Morgan Stanley | Overweight |
모두보기
Cabaletta Bio Inc 주식(CABA)의 최신 뉴스
Certain Stock Options of Cabaletta Bio, Inc. are subject to a Lock-Up Agreement Ending on 11-AUG-2025. - MarketScreener
Certain Common Stock of Cabaletta Bio, Inc. are subject to a Lock-Up Agreement Ending on 11-AUG-2025. - MarketScreener
Cabaletta Bio (CABA) Projected to Post Earnings on Thursday - MarketBeat
Federated Hermes Inc. Has $476,000 Holdings in Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Cabaletta Bio Advances Rese-cel Pipeline as BLA Submission for Myositis Nears - MSN
Wells Fargo Adjusts Price Target for Cabaletta Bio to $2.00, Reflecting a 33.33% Decrease from $3.00. - AInvest
Guggenheim lowers Cabaletta Bio stock price target to $15 on dilution - Investing.com
Cabaletta Bio Reports Progress in Clinical Trials - TipRanks
Jefferies lowers Cabaletta Bio stock price target to $14 from $28 - Investing.com
Cabaletta Bio (CABA) Plans $240M Mixed Securities Offering - GuruFocus
Cabaletta Bio Files $240 Million Shelf Offering - MarketScreener
Cabaletta Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cabaletta Bio’s Promising Clinical Study on CABA-201 for Myasthenia Gravis - TipRanks
Cabaletta Bio Inc files for mixed shelf offering of up to $240 million- SEC filing - MarketScreener
Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update | CABA Stock News - GuruFocus
Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
Cabaletta Bio’s Promising Study on CABA-201 for Myasthenia Gravis: A Potential Game-Changer - TipRanks
Individual investors who have a significant stake must be disappointed along with institutions after Cabaletta Bio, Inc.'s (NASDAQ:CABA) market cap dropped by US$17m - Yahoo Finance
Cabaletta Bio Inc expected to post a loss of 65 cents a shareEarnings Preview - TradingView
Published on: 2025-08-04 17:06:26 - beatles.ru
How does Cabaletta Bio Inc. compare to its industry peersUnlock expert market analysis instantly - Jammu Links News
What institutional investors are buying Cabaletta Bio Inc. stockRapidly expanding wealth - Jammu Links News
How does Cabaletta Bio Inc. generate profit in a changing economyInvest smarter with actionable trading signals - Jammu Links News
What analysts say about Cabaletta Bio Inc. stockAchieve remarkable returns with smart investing - Jammu Links News
Should I hold or sell Cabaletta Bio Inc. stock in 2025Sky-high return potential - Jammu Links News
What is the dividend policy of Cabaletta Bio Inc. stockTurn market volatility into profit opportunities - Jammu Links News
What drives Cabaletta Bio Inc. stock priceUnlock powerful market trend analysis - Jammu Links News
How volatile is Cabaletta Bio Inc. stock compared to the marketConsistently exceptional gains - Jammu Links News
When is Cabaletta Bio Inc. stock expected to show significant growthBreakthrough financial growth - Jammu Links News
Cabaletta Bio Inc. Stock Analysis and ForecastGet ahead with breakthrough trading ideas - Jammu Links News
What catalysts could drive Cabaletta Bio Inc. stock higher in 2025High-performance investment picks - Jammu Links News
Is Cabaletta Bio Inc. a growth stock or a value stockMaximize returns with strategic stock selection - Jammu Links News
What is Cabaletta Bio Inc. company’s growth strategyCapitalize on fast-moving market trends - Jammu Links News
What are Cabaletta Bio Inc. company’s key revenue driversBuild wealth faster with consistent investment plans - Jammu Links News
What is the risk reward ratio of investing in Cabaletta Bio Inc. stockStock Strategy Trend Scanner For Every Investor - Jammu Links News
What’s the recovery path for long term holders of Cabaletta Bio Inc.Multi-Bagger Potential Stock Forecast Tools Released - metal.it
Is it the right time to buy Cabaletta Bio Inc. stockStock Strategy Tracker For Every Investor - Jammu Links News
Cabaletta Bio Inc. Company’s Quarterly Earnings Growth: What the Numbers SayDaily Chart Pattern Stock Forecast Shows Bullish Setup - metal.it
Why Cabaletta Bio Inc. stock attracts strong analyst attentionExit Ready Momentum Stock Watchlist Expanded - metal.it
What makes Cabaletta Bio Inc. stock price move sharplyMarket-beating performance - Jammu Links News
Applying big data sentiment scoring on Cabaletta Bio Inc.High Return Strategy with Low Risk - Newser
Key resistance and support levels for Cabaletta Bio Inc.Market Correction Proof Stock Screening Analysis - Newser
How to track smart money flows in Cabaletta Bio Inc. Profit Target Planning with Exit Confidence - Newser
How strong is Cabaletta Bio Inc. company’s balance sheetMaximize your portfolio’s earning power - jammulinksnews.com
Cabaletta Bio Inc. Company Revenue and Profit Trends: A Deep Dive200 Percent Watchlist - metal.it
Cabaletta Bio Inc (CABA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):